Skip to content Skip to sidebar Skip to footer

Newsletter

Small Caps Stocks

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

In all our years, we have seen our fair share of ASX Company Spin. It is repeated because often investors fall for it. Even if not all do, it is sufficient that some investors fall for it to achieve what has to be achieved. For instance, that enough believe a capital raising at a >25% discount…

ByNick SundichFebruary 19, 2026

Why Investors Are Rotating Into ASX Small Caps- 5 Top Picks for 2026

ASX Small Caps Are Back on the Radar for 2026 An interesting development occurred on the ASX in 2025. While most investors focused on big, well-known stocks, ASX small-cap shares quietly performed much better. The Small Ordinaries Index rose by almost 25 per cent for the year, which is about 2.5…

ByUjjwal MaheshwariFebruary 18, 2026

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

Investors may remember Rhythm Biosciences (ASX:RHY) for its ColoSTAT test, but it is Genetype that is arguably more exciting. The company now has a substantially larger market awaiting us, and while its commercialisation strategy for ColoSTAT has changed, this strategy has been successful. Wait, has Rhythm received TGA approval? Yes and no - it's a long…

ByNick SundichFebruary 17, 2026

Kelly Partners (ASX:KPG): A Home-Grown Accounting Firm With Strong Growth And Expanding Abroad, So Why Is It Falling?

Kelly Partners (ASX:KPG) has endured a growth record very few ASX companies can rival. It boasts 30.3% revenue CAGR since its IPO and is rapidly expanding overseas. So why then is it down nearly 50% in the last year. Let's look into it. What are the Best ASX Stocks to invest in right now? Check our…

ByNick SundichFebruary 12, 2026

Here are 7 ASX stocks that overinflated during the pandemic and crashed; and where they are now

If you want proof the COVID pandemic was a crazy time, just take a look at a list of ASX stocks that overinflated during that time, and how they subsequently crashed. We have put together one such list, it is not intended to be exhaustive, but we think it covers the main 7 that would…

ByNick SundichFebruary 6, 2026

Does your stock suffer from governance issues? Here are 10 hidden red flags!

No investor would invest in a company with governance issues, but it can be difficult to spot red flags. That is why we decided to write this article - to help investors determine them. Because we have seen these happen so many times over the years in so many companies as red flags that there…

ByNick SundichFebruary 6, 2026

Fortuna Metals (ASX:FUN): A unique nearology play for investors – adjacent to the world’s largest known rutile deposit

Fortuna Metals (ASX:FUN) is a classic 'nearology' play for investors, and a unique one at that. 'Nearology plays' have deposits in the same district as larger companies that have had success and the hope is that these companies can have the same success. Often, there can be more than a dozen plays that pitch their…

ByNick SundichFebruary 4, 2026

Green360 Technologies (ASX:GT3): Already revenue generating, but laying the foundations for an enormous future in low-carbon concrete

Green360 Technologies (ASX:GT3) is a peculiar company on the ASX. It has an existing revenue-generating business that unique because it the only company in the wet kaolin processing trade. But GT3 hopes to use this expertise to expand into low carbon concrete with low-carbon precast products and Eco-Clay. What are the Best ASX Stocks to invest…

ByNick SundichFebruary 3, 2026

What happened to Botanix (ASX:BOT) and why are investors sweating

From A$0.53 to A$0.118 Botanix Shows How Fast Biotech Narratives Turn Botanix (ASX:BOT) is a clear example of how quickly sentiment can shift in Australian biotech. The share price has been highly volatile, reaching highs of A$0.53 before falling to A$0.118 today, even after the launch of Sofdra. For context, Sofdra is Botanix’s FDA approved treatment…

ByCharlie YouldenJanuary 27, 2026

Donald Trump Buying Greenland: If This Comes to Fruition, Here’s One Company to Watch

Donald Trump Buying Greenland. This is a prospect that was raised during his first presidency, but has just been raised again. And this was not just a fanciful idea, but he declared 'we need' it for the 'economic security' of the United States - refusing to rule out using military force to obtain it. And…

ByNick SundichJanuary 20, 2026

the Kick-ass Multipurpose WordPress Theme

Small Caps Stocks

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

Why Investors Are Rotating Into ASX Small Caps- 5 Top Picks for 2026

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

Kelly Partners (ASX:KPG): A Home-Grown Accounting Firm With Strong Growth And Expanding Abroad, So Why Is It Falling?

Here are 7 ASX stocks that overinflated during the pandemic and crashed; and where they are now

Does your stock suffer from governance issues? Here are 10 hidden red flags!

Fortuna Metals (ASX:FUN): A unique nearology play for investors – adjacent to the world’s largest known rutile deposit

Green360 Technologies (ASX:GT3): Already revenue generating, but laying the foundations for an enormous future in low-carbon concrete

What happened to Botanix (ASX:BOT) and why are investors sweating

Donald Trump Buying Greenland: If This Comes to Fruition, Here’s One Company to Watch

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Small Caps Stocks

Stocks in Spotlight

Add Your Heading Text Here